Macrophage correlates with immunophenotype and predicts anti-PD-L1 response of urothelial cancer

Immune-checkpoint blockades (ICBs) have been routinely implemented to treat metastatic urothelial cancer (mUC), whereas robust biomarkers are urgently warranted. Herein, we explored latent promising biomarkers based on 348 pretreatment mUC samples from IMvigor210. Methods: The genome, transcriptome,...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Theranostics
Main Authors: Zeng, Dongqiang, Ye, Zilan, Wu, Jiani, Zhou, Rui, Fan, Xinxiang, Wang, Gaofeng, Huang, Yiqiang, Wu, Jianhua, Sun, Huiying, Wang, Miaohong, Bin, Jianping, Liao, Yulin, Li, Nailin, Shi, Min, Liao, Wangjun
Formato: Artigo
Idioma:Inglês
Publicado: Ivyspring International Publisher 2020
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7295060/
https://ncbi.nlm.nih.gov/pubmed/32550918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.46176
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares